• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
Science
Report

Experimental retatrutide reportedly produced 18.8% average weight loss at its highest dose

Medical Xpress reports 5.1% weight loss with placebo over 80 weeks in adults with obesity and type 2 diabetes.

Medical XpressMX
1 Source, 6h ago, first seen 6h ago

TLDR

Medical Xpress reports that the highest dose of retatrutide, an experimental weekly injection, produced 18.8% average weight loss over 80 weeks in adults with obesity and type 2 diabetes, versus 5.1% with placebo.

Combined views

1.6K

1 Source, first seen 6h ago

9 likes2 comments4 saves6 reposts

Combined views

1.6K

1 Source, first seen 6h ago

9 likes2 comments4 saves6 reposts

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

1 Source

Medical Xpress@medical_xpressRetatrutide produced 18.8% average weight loss in adults with obesity and type 2 diabetes at the highest dose over 80 weeks, versus 5.1% with placebo; the weekly injection remains experimental. @TheLancet https://medicalxpress.com/news/2026-10-triple-action-drug-retatrutide-major.html?utm_source=twitter.com&utm_medium=social&utm_campaign=v26h
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI

    1 Source

    Medical Xpress@medical_xpressRetatrutide produced 18.8% average weight loss in adults with obesity and type 2 diabetes at the highest dose over 80 weeks, versus 5.1% with placebo; the weekly injection remains experimental. @TheLancet https://medicalxpress.com/news/2026-10-triple-action-drug-retatrutide-major.html?utm_source=twitter.com&utm_medium=social&utm_campaign=v26h
    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet